Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

Literature DB >> 14993526

Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

Edward Z Tronick¹, Karen Olson, Rebecca Rosenberg, Lisa Bohne, Jing Lu, Barry M Lester.

Abstract

Descriptive statistics for the Neonatal Intensive Care Unit Network Neurobehavioral Scale summary scores are provided for a sample of 125 full-term, healthy 1- to 2-day-old infants. The study sample is described, including demographic characteristics and infant and maternal medical characteristics. Descriptive statistics and percentiles are provided for the Neonatal Intensive Care Unit Network Neurobehavioral Scale summary scores. These tables can be used as quasinorms for comparison with other infants of this age.

Entities: Species

Mesh：

Year: 2004 PMID： 14993526

Source DB: PubMed Journal: Pediatrics ISSN： 0031-4005 Impact factor: 7.124

Keyword Cloud
Cited

34 in total

1. Earliest appropriate time for administering neurobehavioral assessment in newborn infants.

Authors: Yingying Xu; Kimberly Yolton; Jane Khoury
Journal: Pediatrics Date: 2010-12-20 Impact factor: 7.124

2. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.

Authors: Adam J Czynski; Jonathan M Davis; Lynne M Dansereau; Barbara Engelhardt; Peter Marro; Debra L Bogen; Mark L Hudak; Jeffrey Shenberger; Elisha M Wachman; Erica L Oliveira; Barry M Lester
Journal: J Pediatr Date: 2020-01-24 Impact factor: 4.406

Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

1. Earliest appropriate time for administering neurobehavioral assessment in newborn infants.

2. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.

3. Prenatal exposure to polybrominated diphenyl ethers and polyfluoroalkyl chemicals and infant neurobehavior.

4. Placenta-imprinted gene expression association of infant neurobehavior.

5. Prenatal exposure to bisphenol A and phthalates and infant neurobehavior.

6. Sex-specific associations between placental leptin promoter DNA methylation and infant neurobehavior.

7. Patterns of altered neurobehavior in preterm infants within the neonatal intensive care unit.

8. Prenatal methadone exposure and neonatal neurobehavioral functioning.

9. Low-level prenatal exposure to nicotine and infant neurobehavior.

10. Factors associated with developmental concern and intent to access therapy following discharge from the NICU.